Admedus Ltd (AHZ) - Research

$0.060

AHZ General Information +

ASX Code AHZ
Website http://www.admedus.com
GICS Sub-Industry Health Care Supplies
Market Cap ($M) 35
Current Price $0.060
Day High $0.000
Day Low $0.000
Last Close $0.060
Price Movement - ( No change )
Prices as at 16:40, 19 Jul 2019
+Security prices are delayed by at least 20 minutes and are indicative only.

AHZ Company Overview

Business Description

Admedus Ltd (AHZ) is a diversified healthcare company investing in and developing next generation technologies of medical devices. The Company focuses on commercializing tissue engineering technology for use in cardiovascular and soft tissue repair surgery. AHZ Operates in four segments: Medical products and devices, Bio Implant operations, Regenerative medicine R&D and Immunotherapies R&D, Infusion business.

AHZ Financial Summary

Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2018 A -24.70 -7.90 0.00% 0.00 0.00 0.00% 0.0%
2017 A -8.83 -3.40 0.00% 0.00 0.00 0.00% 0.0%
2016 A -25.13 -12.60 0.00% 0.00 0.00 0.00% 0.0%

AHZ Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2016 A 2017 A 2018 A 2016 A 2017 A 2018 A 2016 A 2017 A 2018 A
Admedus (AHZ) $35M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Ansell (ANN) $3,548M 0.2833 0.0922 0.1007 19.7131 18.0496 16.3985 2.30% 2.47% 2.70%
Nanosonics (NAN) $1,542M -0.7807 1.2775 0.0667 269.1099 118.1609 110.7759 0.00% 0.00% 0.00%
Polynovo (PNV) $1,104M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

AHZ Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.68 0.00
Market 0.68 14.80 1.18 1.00
Sector 1.14 17.70 1.85 3.17

AHZ Directors

Name Position Start Date
Mr Stephen (Steve) Denaro Company Secretary, Non-Executive Director 31 Oct 2018
Mr Wayne Paterson Managing Director, Chief Executive Officer 10 Oct 2014
Dr Wenyi Gu Non-Executive Director 4 Oct 2018
Dr Yanheng Wu Non-Executive Director 12 Dec 2018
Mr John Seaberg Non-Executive Director, Non-Executive Chairman 10 Oct 2014

AHZ Management

Name Position
Kiran Bhirangi Chief Medical Officer
David St Denis Chief Operating Officer
Matthew McDonnell Interim Chief Financial Officer

AHZ Substantial Shareholders

Holding Name
133,453,435 (22.62%) Star Bright Holding Limited
131,120,851 (22.23%) Sio Partners LP

AHZ Calendar of Events

Date Event
10 April 2020 Report (Annual)
28 February 2020 Report (Prelim)
02 September 2019 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.